2010
DOI: 10.1007/s10072-010-0239-z
|View full text |Cite
|
Sign up to set email alerts
|

Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases

Abstract: Radiolabeled metaiodobenzylguanidine (MIBG) is an analog of guanethidine and is taken up by the postganglionic presynaptic nerve endings. MIBG uptake in the heart correlates with adrenergic function, which can be reduced in Lewy body diseases. We described the recent developments in innervation imaging using (123)I-MIBG scintigraphy in Lewy body diseases including Parkinson's disease and dementia with Lewy bodies. Particularly, we underlined the role of MIBG scintigraphy in differential diagnosis of movement d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
50
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
1

Relationship

4
2

Authors

Journals

citations
Cited by 21 publications
(51 citation statements)
references
References 34 publications
1
50
0
Order By: Relevance
“…Several MIBG studies have demonstrated that cardiac sympathetic denervation occurs in patients with LBD. [2][3][4][6][7][8] Treglia et al Recent evidence supports the notion that myocardial sympathetic involvement is a very early event in the evolution of LBD in humans, occurring prior to the deposition of α-synuclein pathology in the central nervous system in many patients. 9,10 Several investigators have, therefore, suggested that myocardial MIBG scintigraphy could be used to identify those with underlying LBD regardless of the other clinical features being exhibited; therefore, reduced myocardial MIBG uptake may be one of the most specific biomarkers for underlying LBD.…”
Section: Introductionmentioning
confidence: 82%
See 4 more Smart Citations
“…Several MIBG studies have demonstrated that cardiac sympathetic denervation occurs in patients with LBD. [2][3][4][6][7][8] Treglia et al Recent evidence supports the notion that myocardial sympathetic involvement is a very early event in the evolution of LBD in humans, occurring prior to the deposition of α-synuclein pathology in the central nervous system in many patients. 9,10 Several investigators have, therefore, suggested that myocardial MIBG scintigraphy could be used to identify those with underlying LBD regardless of the other clinical features being exhibited; therefore, reduced myocardial MIBG uptake may be one of the most specific biomarkers for underlying LBD.…”
Section: Introductionmentioning
confidence: 82%
“…Labeling MIBG with iodine-123 permits the visualization of adrenergic innervation in vivo; MIBG scintigraphy not only displays the presence of noradrenergic innervation, but also its functional capability. [1][2][3][4] About myocardial innervation imaging, radiolabeled MIBG is intravenously administered at rest, and early (from 10 to 30 min after injection) and delayed (from 3 to 4 h after injection) images are obtained (see Figures 1 and 2). Planar images with anterior view are adequate for the evaluation of cardiac sympathetic function.…”
Section: Scintigraphic Methodsmentioning
confidence: 99%
See 3 more Smart Citations